Literature DB >> 20563916

The interactive effect of exercise and immunosuppressant cyclosporin A on immune function in mice.

Miau-Hwa Ko1, Chen-Kang Chang, Ching-Lin Wu, Yu-Chi Hou, Wei Hong, Shih-Hua Fang.   

Abstract

Cyclosporin A (CsA) is an effective immunosuppressive agent and exerts its actions by interfering with the activation of T cells. There is growing evidence that regular exercise improves immune function. However, the effects of exercise on immune functions in patients taking CsA are unclear. Here, we examine the interactive effects of CsA administration and regular exercise on immune function in mice. Forty-eight BALB/c mice were randomly assigned to one of six groups with eight mice per group: 0-Ex (no CsA/no exercise), 0 + Ex (no CsA + exercise), 10-Ex (10 mg kg(-1) day(-1) CsA/no exercise), 10 + Ex (10 mg kg(-1) day(-1) CsA + exercise), 20-Ex (20 mg kg(-1) day(-1) CsA/no exercise), and 20 + Ex (20 mg kg(-1) day(-1) CsA + exercise). The three exercise groups were trained for 8 weeks, three times a week, at approximately 75% maximum oxygen uptake (VO(2max)). Nitric oxide and interferon-gamma secretions by mitogen-activated macrophages and spleen cells, respectively, were higher in exercise groups than in non-exercise groups receiving the same doses of CsA. The results of this study indicate that regular exercise may enhance Type I helper T cell functions in mice receiving 10 or 20 mg kg(-1) day(-1) CsA. Our results demonstrate that moderate regular exercise modulates the immune function of CsA-treated mice. However, whether this exercise-induced immunomodulatory effect is beneficial or detrimental to CsA-treated patients needs to be clarified.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20563916     DOI: 10.1080/02640414.2010.481306

Source DB:  PubMed          Journal:  J Sports Sci        ISSN: 0264-0414            Impact factor:   3.337


  1 in total

Review 1.  Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients.

Authors:  C Fiuza-Luces; R J Simpson; M Ramírez; A Lucia; N A Berger
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.